Health Care · Pharmaceutical Preparations · OTC · CIK 1527599 · FYE Dec 31 · Prices AT CLOSE 2026-08-18 (USD) Last $1.20 · Day +0.00% · Mkt cap $15M · 1Y −16.1% · Off 52W high −35.8% · Vol (1Y) 92.7% Price2023-08-18 → 2026-08-18 SYBX close: $7.84 on 2023-08-18 to $1.20 on 2026-08-18. Split-adj closes · 240 of 2,734 · price returnⓘ At a glance | Short interest0.3% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)−0.00% | | Top-10 13F concentration100.0% | | Next report (est.)2026-11-10 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$0 | | Earnings (TTM)-$655,000 | | ROE−8.2% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+7.1% | | 1Y−16.1% | | 3Y−84.7% | | 5Y−97.0% | | 10Y−99.6% | | Since incept. (ann.)−44.6% |
Total return · from 2015-10-01ⓘ Risk | Ann. volatility (1Y)92.7% | | Ann. volatility (3Y)87.7% | | Sharpe (1Y)0.30 | | Sharpe (3Y)−0.23 | | Max drawdown (1Y)−69.4% | | Max drawdown (3Y)−93.1% | | Beta (3Y vs SPY)1.80 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| DRW Securities, LLC | 23,763 | $14,495 | 0.20% | −2.5% | | Hilltop National Bank | 20 | $12 | 0.00% | +0.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-11 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-11 | −$0.04 | — | $0 | — | | 2026-03-31 | 2026-05-14 | $0.05 | +66.7% | $0 | — | | 2025-12-31 | 2026-03-12 | — | — | $0 | — | | 2025-09-30 | 2025-11-13 | −$0.19 | — | $0 | — |
As-reported XBRL · next 2026-11-10 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
